Package 51662-1638-3

{"route": ["PERINEURAL"], "spl_id": "0f952dd8-92a8-2eb0-e063-6394a90a8c35", "openfda": {"unii": ["7TQO7W3VT8"], "rxcui": ["1012404"], "spl_set_id": ["06c15208-c600-7173-e063-6394a90a2f94"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "25 POUCH in 1 CASE (51662-1638-3)  / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1638-2)  / 50 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1638-3", "marketing_start_date": "20231002"}], "brand_name": "BUPIVACAINE HYDROCHLORIDE injection, solution", "product_id": "51662-1638_0f952dd8-92a8-2eb0-e063-6394a90a8c35", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Local Anesthesia [PE]"], "product_ndc": "51662-1638", "generic_name": "BUPIVACAINE HYDROCHLORIDE injection, solution", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPIVACAINE HYDROCHLORIDE injection, solution", "active_ingredients": [{"name": "BUPIVACAINE HYDROCHLORIDE", "strength": "5 mg/mL"}], "application_number": "ANDA207183", "marketing_category": "ANDA", "marketing_start_date": "20160513", "listing_expiration_date": "20261231"}